Biodesix, Inc. provided a corporate update and announced its financial and operating results for the fourth quarter and year ended December 31, 2023 (fiscal 2023). “I...
Spyre Therapeutics, Inc. announced that Spyre’s independent Compensation Committee of the Board of Directors approved the grants of stock options to purchase an aggregate of 166,200...
Know Labs, Inc. announced it has entered into a funding agreement for an investment of up to $12 million, of which it has executed a $4...
Taysha Gene Therapies, Inc. announced that, on March 1, 2024, the Compensation Committee of Taysha’s Board of Directors granted four new employees, in the aggregate, options...
Precision BioSciences, Inc. announced that it has agreed to sell to the public by way of an underwritten offering 2,500,000 shares of its common stock and...
CooperCompanies announced financial results for its fiscal first quarter ended January 31, 2024. Revenue increased 9% year-over-year to $931.6 million. CooperVision (CVI) revenue up 7% to $621.5...
Kenai Therapeutics announced an $82 million Series A financing co-led by Alaska Permanent Fund Corporation, Cure Ventures and The Column Group, with participation from Euclidean Capital...
Humacyte, Inc. announced that it has commenced an underwritten public offering of its common stock. In addition, Humacyte intends to grant the underwriters an option for...
Adicet Bio, Inc. announced it granted an inducement award on February 29, 2024. One individual was hired by Adicet in February 2024 and granted new hire...
ClearPoint Neuro, Inc. announced the pricing of its underwritten public offering of 2,307,694 shares of its common stock at a price to the public of $6.50...
TransMedics Group, Inc. announced that on February 23, 2024, TransMedics granted non-qualified stock options to purchase an aggregate of 3,815 shares of its common stock and...
Zynex, Inc. reported its financial and operational results for the fourth quarter and full year ended December 31, 2023 and its Board of Directors has approved...
RxSight, Inc. reported financial results for the three months and full year ended December 31, 2023. “We are very thankful to all our partner doctors and...
Veradigm Inc. announced that, as expected, it received a notice from The Nasdaq Stock Market LLC indicating that the Nasdaq Hearings Panel (the “Panel”) has determined...
EMVision has announced a US$10 million (~A$15.28m) strategic investment from Keysight Technologies, a global leader in test and measurement technology. The investment provides EMVision with a...
Copyright © 2024 Medical Buyer